Clear All
11561 Matching Results — Export these results
Click column titles once to sort ascending, and twice to sort descending.
NDC-11 (Package) NDC-9 (Product) Generic Name Brand Name Strength SEER*Rx Category Major Class Minor Class Administration Route Package Effective Date Package Discontinuation Date Status
72578-0168-01 72578-0168 Dexamethasone Dexamethasone 0.5 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral Apr 15, 2024 In Use
70771-1705-01 70771-1705 Dexamethasone Dexamethasone 0.75 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral Apr 15, 2024 In Use
72578-0167-01 72578-0167 Dexamethasone Dexamethasone 2.0 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral Apr 15, 2024 In Use
70771-1701-01 70771-1701 Dexamethasone Dexamethasone 2.0 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral Apr 15, 2024 In Use
72578-0169-01 72578-0169 Dexamethasone Dexamethasone 0.75 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral Apr 15, 2024 In Use
70771-1700-01 70771-1700 Dexamethasone Dexamethasone 6.0 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral Apr 15, 2024 In Use
70771-1699-01 70771-1699 Dexamethasone Dexamethasone 4.0 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral Apr 15, 2024 In Use
70518-4038-01 70518-4038 PREDNISONE Prednisone 10.0 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral Apr 15, 2024 In Use
70771-1704-01 70771-1704 Dexamethasone Dexamethasone 0.5 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral Apr 15, 2024 In Use
70771-1707-01 70771-1707 Dexamethasone Dexamethasone 1.5 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral Apr 15, 2024 In Use
65862-0390-05 65862-0390 Ondansetron Ondansetron 4.0 mg/1 Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Oral Apr 12, 2024 In Use
65862-0391-02 65862-0391 Ondansetron Ondansetron 8.0 mg/1 Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Oral Apr 12, 2024 In Use
65862-0391-05 65862-0391 Ondansetron Ondansetron 8.0 mg/1 Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Oral Apr 12, 2024 In Use
00002-5340-60 00002-5340 Selpercatinib RETEVMO 40.0 mg/1 Chemotherapy Tyrosine Kinase Inhibitor VEGFR, RET Oral Apr 10, 2024 In Use
00002-5562-60 00002-5562 Selpercatinib RETEVMO 160.0 mg/1 Chemotherapy Tyrosine Kinase Inhibitor VEGFR, RET Oral Apr 10, 2024 In Use
00002-6082-60 00002-6082 Selpercatinib RETEVMO 80.0 mg/1 Chemotherapy Tyrosine Kinase Inhibitor VEGFR, RET Oral Apr 10, 2024 In Use
70518-4045-00 70518-4045 METHYLPREDNISOLONE ACETATE METHYLPREDNISOLONE ACETATE 80.0 mg/mL Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Intralesional, Intramuscular, Intrasynovial, Soft Tissue Apr 10, 2024 In Use
00002-6120-60 00002-6120 Selpercatinib RETEVMO 120.0 mg/1 Chemotherapy Tyrosine Kinase Inhibitor VEGFR, RET Oral Apr 10, 2024 In Use
60760-0796-21 60760-0796 PredniSONE PredniSONE 5.0 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral Apr 9, 2024 In Use
68788-8626-06 68788-8626 Estradiol Estradiol 0.5 mg/1 Hormonal Therapy Estrogen Oral Apr 9, 2024 In Use
68788-8626-03 68788-8626 Estradiol Estradiol 0.5 mg/1 Hormonal Therapy Estrogen Oral Apr 9, 2024 In Use
68788-8626-09 68788-8626 Estradiol Estradiol 0.5 mg/1 Hormonal Therapy Estrogen Oral Apr 9, 2024 In Use
68788-8626-01 68788-8626 Estradiol Estradiol 0.5 mg/1 Hormonal Therapy Estrogen Oral Apr 9, 2024 In Use
00781-3528-10 00781-3528 Cyclophosphamide Cyclophosphamide 500.0 mg/5mL Chemotherapy Alkylating Agent Nitrogen Mustard Intravenous Apr 8, 2024 In Use
00781-3530-10 00781-3530 Cyclophosphamide Cyclophosphamide 2000.0 mg/20mL Chemotherapy Alkylating Agent Nitrogen Mustard Intravenous Apr 8, 2024 In Use

Found 11561 results — Export these results